XtendOvite
XtendOvite, licence 80044446: active licence in Health Canada data. The French and European references below do not constitute authorisation for sale in France or an assessment of safety or efficacy.
Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks, retrieved 27 October 2026.
Contains information licensed under the Open Government Licence – Canada (Health Canada, LNHPD)
Licence du gouvernement ouvert – Canada 2.0 (OGL-Canada 2.0)
Natural health product licensed in Canada
- Licence holder
- Heart Drop 2000 Distribution Inc.
- NPN or DIN-HM
- 80044446
- Status
- Active licence
- Licence date
- 28 August 2013
- Revision date
- Not provided
- Form
- Capsule
- Route of administration
- Orale
- Application type
- Non traditionnelle
If this product were sold in France
- Conditions légales
Valeriana officinalis L.: L'absence de valépotriates doit être prouvée par des rapports d'analyse. L'étiquetage doit comporter un avertissement déconseillant l'emploi aux enfants de moins de 12 ans.
arrêté du 24 juin 2014, annexe I. French orders of 9 May 2006 (nutrients), 24 June 2014 (plants) and 26 September 2016 (other substances), consolidated LEGI collection, retrieved 23 October 2026.
- Conditions légales
Ginkgo biloba L.: L'étiquetage des compléments alimentaires qui contiennent la feuille de la plante Ginkgo biloba L. doit comporter un avertissement avec la teneur suivante: "Consultez votre médecin en cas de prise simultanée d'anticoagulants."
arrêté du 24 juin 2014, annexe I. French orders of 9 May 2006 (nutrients), 24 June 2014 (plants) and 26 September 2016 (other substances), consolidated LEGI collection, retrieved 23 October 2026.
A daily quantity is calculated only for an explicit adult oral dosage, stated per day and in a solid unit matching the product form. Ambiguous units, liquids, powders and paediatric doses are not extrapolated. A quantity not calculated is not compared with dose limits. This analysis does not constitute authorisation for sale in France or an assessment of safety or efficacy.
Composition
| Medicinal ingredient and source | Per dosage unit, according to the source | Maximum per day, adult |
|---|---|---|
| Valeriana officinalis Source : Racine | 75.0 mg | Not calculated |
| Allium sativum Source : Bulbe Extraction ratio : 20:1 Dry plant equivalent : 1500 mg Potency : 1.0 % Allicin | 75.0 mg | Not calculated |
| Ginkgo biloba Source : Feuille Extraction ratio : 10:1 Dry plant equivalent : 300 mg Potency : 6.0 % Terpene lactones | 30.0 mg | Not calculated |
| Ginkgo biloba Source : Feuille Potency : 24.0 % Flavonoid glycosides | Not specified | Not calculated |
| Capsicum annuum Source : Fruit | 75.0 mg | Not calculated |
| Silybum marianum Source : Graine(s) | 30.0 mg | Not calculated |
Non-medicinal ingredients
Hypromellose
Recommended doses in Canada
| Population | Age | Quantity per serving | Frequency |
|---|---|---|---|
| Adultes | Not specified | 2.0 Capsule | 2.0 Jour(s) |
Uses authorised in Canada
Garlic is used in Herbal Medicine to help maintain cardiovascular health in adults. Garlic is used in Herbal Medicine to help reduce elevated blood lipid levels/hyperlipidaemia in adults.
A use authorised in Canada is not an authorised health claim in the European Union. See the health claims register.
Warnings in Canada
- Précautions et mises en garde
Consult a health care practitioner if symptoms persist or worsen. Consult a health care practitioner prior to use if you are pregnant or if you have diabetes. Consult a health care practitioner prior to use if you are taking medications for, diabetes, high blood pressure, seizures, protease inhibitors or cardiac glycosides such as digitalis/digoxin. Consumption with alcohol, other medications or natural health products with sedative properties is not recommended. Consult a health care practitioner prior to use if you have stomach ulcers or inflammation. Consult a health care practitioner prior to use if you are breastfeeding.
- Contre-indications
Do not use if you are taking health products that affect blood coagulation (e.g. blood thinners, clotting factor replacements, acetylsalicylic acid, ibuprofen, fish oils, vitamin E) as this may increase the risk of spontaneous bleeding.
- Effets indésirables connus
Hypersensitivity (e.g. allergy) has been known to occur; in which case discontinue use. Some people may experience drowsiness. Exercise caution if operating heavy machinery, driving a motor vehicle or involved in activities requiring mental alertness within 2 hours of consumption.
Source
Official Health Canada record, licence 80044446
The formula sold in Europe under the same name may differ. This information does not replace advice from a doctor or pharmacist.
The evidence date of this ingredient list is unknown.
Has the product changed? Photograph the packaging.